1
|
Yamaguchi M, Suzuki R and Oguchi M:
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal
type. Blood. 131:2528–2540. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chan JKC, Quintanilla-Martinez L and Ferry
JA: WHO classification of tumor of hematopoietic and lymphoid
tissues (Revised 4th edition)IARC; Lyon: pp. 368–371. 2017
|
3
|
Kang DH, Huh J, Lee JH, Jeong YK and Cha
HJ: Gastrosplenic fistula occurring in lymphoma patients:
Systematic review with a new case of extranodal NK/T-cell lymphoma.
World J Gastroenterol. 23:6491–6499. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Liang P, Ren XC and Gao JB: Radiological
and clinical features of primary NK/T-cell lymphoma involving the
whole length of the esophagus: A case report. Oncol Lett.
14:2147–2152. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Haverkos BM, Pan Z, Gru AA, Freud AG,
Rabinovitch R, Xu-Welliver M, Otto B, Barrionuevo C, Baiocchi RA,
Rochford R and Porcu P: Extranodal NK/T cell lymphoma, nasal type
(ENKTL-NT): An update on epidemiology, clinical presentation, and
natural history in North American and European cases. Curr Hematol
Malig Rep. 11:514–527. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Tse E and Kwong YL: Diagnosis and
management of extranodal NK/T cell lymphoma nasal type. Expert Rev
Hematol. 9:861–871. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zanelli M, Mengoli MC, Del Sordo R, Cagini
A, De Marco L, Simonetti E, Martino G, Zizzo M and Ascani S:
Intravascular NK/T-cell lymphoma, Epstein-Barr virus positive with
multiorgan involvement: A clinical dilemma. BMC Cancer.
18:11152018. View Article : Google Scholar : PubMed/NCBI
|
8
|
Sinkovics JG and Horvath JC: Human natural
killer cells: A comprehensive review. Int J Oncol. 27:5–47.
2005.PubMed/NCBI
|
9
|
Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P,
Konoplev S, Bueso-Ramos CE, Vega F, Medeiros LJ and Yin CC:
Extranodal NK/T-cell lymphoma, nasal type: A report of 73 cases at
MD Anderson cancer center. Am J Surg Pathol. 37:14–23. 2013.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Cook JR, Isaacson PG, Chott A, Nakamura S,
Muller-Hermelink HK, Harris NL and Swerdlow SH: WHO classification
of tumor of hematopoietic and lymphoid tissues (Revised 4th
edition)IARC; Lyon: pp. 259–262. 2017
|
11
|
Coha B, Vucinic I, Mahovne I and
Vukovic-Arar Z: Extranodal lymphomas of head and neck with emphasis
on NK/T-cell lymphoma, nasal type. J Craniomaxillofac Surg.
42:149–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Takeuchi K, Yokoyama M, Ishizawa S, Terui
Y, Nomura K, Marutsuka K, Nunomura M, Fukushima N, Yagyuu T,
Nakamine H, et al: Lymphomatoid gastropathy: A distinct
clinicopathologic entity of self-limited pseudomalignant NK-cell
proliferation. Blood. 116:5631–5637. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM,
et al: WHO classification of tumours of hematopoietic and lymphoid
tissues, revised 4th editionIARC; Lyon: 2017
|
14
|
Kimura H and Cohen JI: Chronic active
Epstein-Barr virus disease. Front Immunol. 8:18672017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hu LM, Takata K, Miyata-Takata T, Asano N,
Takahashi E, Furukawa K, Miyoshi H, Satou A, Kohno K, Kosugi H, et
al: Clinicopathological analysis of 12 patients with Epstein-Barr
virus-positive primary intestinal T/natural killer-cell lymphoma
(EBV+ ITNKL). Histopathology. 70:1052–1063. 2017.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Kimura H: EBV in T-/NK-cell tumorigenesis.
Adv Exp Med Biol. 1045:459–475. 2018. View Article : Google Scholar : PubMed/NCBI
|
17
|
Uemura Y, Isobe Y, Uchida A, Asano J,
Nishio Y, Sakai H, Hoshikawa M, Takagi M, Nakamura N and Miura I:
Expression of activating natural killer-cell receptors is a
hallmark of the innate-like T-cell neoplasm in peripheral T-cell
lymphomas. Cancer Sci. 109:1254–1262. 2018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hourdequin KC, Lefferts JA, Brennick JB,
Ernstoff MS, Tsongalis GJ and Pipas JM: Merkel cell polyomavirus
and extrapulmonary small cell carcinoma. Oncol Lett. 6:1049–1052.
2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ding W, Wang J, Zhao S, Yang Q, Sun H, Yan
J, Gao L, Yao W, Zhang W and Liu W: Clinicopathological study of
pulmonary extranodal nature killer/T-cell lymphoma, nasal type and
literature review. Pathol Res Pract. 211:544–549. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ganti A, Raman A, Shay A, Kuhar HN, Auger
SR, Patel T, Kuan EC, Diaz AZ, Batra PS and Tajudeen BA: Treatment
modalities in sinonasal mucosal melanoma: A national cancer
database analysis. Laryngoscope. Apr 25–2019.(Epub ahead of print).
View Article : Google Scholar
|
21
|
Bourne TD, Bellizzi AM, Stelow EB, Loy AH,
Levine PA, Wick MR and Mills SE: p63 Expression in olfactory
neuroblastoma and other small cell tumors of the sinonasal tract.
Am J Clin Pathol. 130:213–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wu Y, Li C, Zhong Y, Guo W and Ren G: Head
and neck rhabdomyosarcoma in adults. J Craniofac Surg. 25:922–925.
2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Jiménez-Heffernan JA, González-Peramato P,
Perna C, Alvarez-Ferreira J, López-Ferrer P and Viguer JM:
Fine-needle aspiration cytology of extranodal natural killer/T-cell
lymphoma. Diagn Cytopathol. 27:371–374. 2002. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wooff JC, Weinreb I, Perez-Ordonez B,
Magee JF and Bullock MJ: Calretinin staining facilitates
differentiation of olfactory neuroblastoma from other small round
blue cell tumors in the sinonasal tract. Am J Surg Pathol.
35:1786–1793. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Aozasa K, Takakuwa T, Hongyo T and Yang
WI: Nasal NK/T-cell lymphoma: Epidemiology and pathogenesis. Int J
Hematol. 87:110–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Huang HS, Liao CK, Liu TT, You HL, Wang MC
and Huang WT: TP53 mutations in peripheral mature T and NK cell
lymphomas: A whole-exome sequencing study with correlation to p53
expression. Hum Pathol. 80:145–151. 2018. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhou J, Zhang C, Sui X, Cao S, Tang F, Sun
S, Wang S and Chen B: Histone deacetylase inhibitor chidamide
induces growth inhibition and apoptosis in NK/T lymphoma cells
through ATM-Chk2-p53-p21 signalling pathway. Invest New Drugs.
36:571–580. 2018. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kuo TT, Shih LY and Tsang NM: Nasal NK/T
cell lymphoma in Taiwan: A clinicopathologic study of 22 cases,
with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene
association, and treatment modalities. Int J Surg Pathol.
12:375–387. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
McKelvie PA, Climent F, Krings G,
Hasserjian RP, Abramson JS, Pilch BZ, Harris NL, Ferry JA,
Zukerberg LR and Sohani AR: Small-cell predominant extranodal NK/T
cell lymphoma, nasal type: Clinicopathological analysis of a series
of cases diagnosed in a Western population. Histopathology.
69:667–679. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Au WY, Weisenburger DD, Intragumtornchai
T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO and Liang R;
International Peripheral T-Cell Lymphoma Project, : Clinical
differences between nasal and extranasal natural killer/T-cell
lymphoma: A study of 136 cases from the International peripheral
T-Cell lymphoma project. Blood. 113:3931–3937. 2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS,
Yhim HY, Kwak JY, Do YR, Park Y, Song MK, et al: Clinical impact of
induction treatment modalities and optimal timing of radiotherapy
for the treatment of limited-stage NK/T cell lymphoma. Leuk Res.
49:80–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yamaguchi M and Miyazaki K: Current
treatment approaches for NK/T-cell lymphoma. J Clin Exp Hematop.
57:98–108. 2017. View Article : Google Scholar : PubMed/NCBI
|